Verantos, Inc.

Digital health · Private

Automated natural language processing system that extracts and validates medical conditions from electronic health records to build accurate patient problem lists

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Digital health
Total capital: $3.9M

Federal grants: $3.9M; 3 awards · 2018–2020; Rank in peer group#13 of 32
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 4; 6 pending · first 2022; Rank in peer group#4 of 32

Capital timeline

Latest events

Dec 2020Federal grantNSF · Phase II · SBIR Phase II: Determination of complex outcome measures using narrative clinical data to enable observational trials$1.7M
Aug 2019Federal grantHealth and Human S · Phase II · Leveraging advanced clinical phenotyping to enhance problem lists and support value-based healthcare$750K
Sep 2018Federal grantHealth and Human S · Phase II · Leveraging advanced clinical phenotyping to enhance problem lists and support value-based healthcare$1.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 32 peers

Line = median

Digital health · Software

Federal grants#13 · top 41%
Granted patents#4 · top 13%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 4 granted of 10

May 21, 2024GrantedSystem And Method For Term DisambiguationUSPTOUS 11,989,511
Dec 7, 2023PendingDevelopment And Use Of Feature Maps From Clinical Data Using Inference And Machine Learning ApproachesUSPTOApplication 17830127
Oct 12, 2023PendingHigh Validity Real-world Evidence Study With Deep PhenotypingUSPTOApplication 18330878

Show all 10 patent records

System And Method For Term DisambiguationMay 21, 2024 · US 11,989,511Granted
Development And Use Of Feature Maps From Clinical Data Using Inference And Machine Learning ApproachesDec 7, 2023 · Application 17830127Pending
High Validity Real-world Evidence Study With Deep PhenotypingOct 12, 2023 · Application 18330878Pending
System And Method For Term DisambiguationAug 15, 2023 · US 11,727,208Granted
High Validity Real-world Evidence Study With Deep PhenotypingJul 25, 2023 · US 11,710,574Granted
System And Method For Term DisambiguationNov 8, 2022 · US 11,494,557Granted
High Validity Real-world Evidence Study With Deep PhenotypingApplication 63142432Pending
System And Method For Term DisambiguationApplication PCTUS2022013345Pending
High Validity Real-world Evidence Study With Deep PhenotypingApplication PCTUS2022013326Pending
System And Method For Term DisambiguationApplication 63189340Pending

BIONIKS, INC.Similar federal contract value in Digital health · null in contracts
BSOLUTIONS, INC.Similar federal contract value in Digital health · null in contracts
SOFTHREAD, INC.Similar federal contract value in Digital health · null in contracts
HIDALGA TECHNOLOGIES, LLCSimilar federal contract value in Digital health · null in contracts
EYENUK, INC.Similar federal contract value in Digital health · null in contracts
ZEBRAMD INC.Similar federal contract value in Digital health · null in contracts

Regulatory activity · Digital health

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.